Corcept Therapeutics (CORT) Enterprise Value (2010 - 2026)
Corcept Therapeutics (CORT) posted Enterprise Value of -$308.2 million for Q2 2026, up 8.87% sequentially from -$338.2 million in Q1 2026, and up 9.94% YoY from -$280.3 million in Q2 2025.
Corcept Therapeutics (CORT) Enterprise Value (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Enterprise Value for 17 years, with the latest figure at -$308.2 million in Q2 2026.
- Quarterly Enterprise Value rose 9.94% year-over-year to -$308.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$308.2 million (up 9.94% YoY) and the FY2025 annual result came in at -$372.2 million, up 2.92% from the prior year.
- Enterprise Value climbed to -$308.2 million in Q2 2026 per CORT's latest filing, from -$338.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$308.2 million in Q2 2026 and troughed at -$473.2 million in Q2 2024.
- A 5-year average of -$380.5 million and a median of -$371.1 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value plunged 93.11% in 2022, then rose 27.67% in 2025.
- Over 5 years, Enterprise Value stood at -$431.7 million in 2022, then gained by 14.7% to -$368.2 million in 2023, then decreased by 4.1% to -$383.3 million in 2024, then grew by 2.92% to -$372.2 million in 2025, then increased by 17.19% to -$308.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$308.2 million, -$338.2 million, and -$372.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | -308.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -308.20 Mn |
| Mar 31, 2026 | -338.18 Mn |
| Dec 31, 2025 | -372.15 Mn |
| Sep 30, 2025 | -421.68 Mn |
| Jun 30, 2025 | -342.23 Mn |
| Mar 31, 2025 | -322.76 Mn |
| Dec 31, 2024 | -383.33 Mn |
| Sep 30, 2024 | -380.34 Mn |
| Jun 30, 2024 | -473.16 Mn |
| Mar 31, 2024 | -410.76 Mn |
| Dec 31, 2023 | -368.22 Mn |
| Sep 30, 2023 | -355.23 Mn |
| Jun 30, 2023 | -363.26 Mn |
| Mar 31, 2023 | -465.06 Mn |
| Dec 31, 2022 | -431.67 Mn |
| Sep 30, 2022 | -396.26 Mn |
| Jun 30, 2022 | -370.09 Mn |
| Mar 31, 2022 | -345.53 Mn |
| Dec 31, 2021 | -223.54 Mn |
| Sep 30, 2021 | -361.33 Mn |